About ADORABLE
Our Mission
The ADORABLE consortium is dedicated to improving the outcomes of kidney transplantation by developing an AI-powered, biomarker-based decision support tool. Our goal is to help clinicians assess donor kidney quality more accurately—ensuring each organ has the best possible chance of long-term success.
Our Vision
We look ahead to a future where every donated kidney is used to its fullest potential, improving both patient outcomes and healthcare system efficiency.
- Short-term (2025–2030): Deliver a clinically validated AI tool, obtain CE certification, and integrate it into transplant decision-making in the Netherlands.
- Long-term (by 2035): Reduce kidney transplant failures by 20% and increase the number of deceased donor transplants from 500 to 550 per year—significantly shortening waiting lists and enhancing quality of life for patients.
ADORABLE Consortium Research Partners
WP leaders and institutes currently taking part in the ADORABLE consortium network:
Coordinator: Prof Martin de Borst (UMCG, Department of Nephrology)
WP1 Biomarker-based prediction of graft survival: Prof Stephan Bakker (UMCG, Department of Nephrology)
WP2 Predictive value of kidney biopsies: Prof Jan-Luuk Hillebrands (UMCG, Department of Pathology & Medical Biology)
WP3 Algorithm development: Prof Martin de Borst (UMCG, Department of Nephrology)
WP4 Professional, patient and economic perspectives: Emma Massey, PhD (Erasmus MC, Department of Nephrology & Transplantation)
WP5 Evaluation, implementation and stakeholder involvement: Rick Pleijhuis, PhD (Evidencio; UMCG department of Internal Medicine)
Why ADORABLE is unique
- The ADORABLE consortium facilitates interdisciplinary excellence by bringing together leading university medical centres (UMCG, Erasmus MC, UMC Utrecht, University of Twente), biomarker technology experts, AI specialists, and patient organisations.
- The patient-centred approach ensures that patients actively contribute as co-researchers (WP4), ensuring our solutions are relevant, usable, and ethically sound.
- The cutting-edge science of combining advanced biomarker discovery with machine learning algorithms creates a new standard in donor organ assessment.
Would you like to know more about our consortium? Please reach out to us at info@adorable-consortium.org and we will get back to you as soon as possible.
